— Jun Oh, MD
Jun Oh's scientific interests are in elucidating the pathogenesis of proteinuric diseases and transplantation immunology. He currently serves on the board of the German Society for Pediatric Nephrology (GPN), the European Society of Pediatric Nephrology (ESPN) and is a member of the educational committee of the International Transplantation Pediatric Association (IPTA) and the International Pediatric Nephrology Association (IPNA). He published over 100 peer-reviewed papers and book-chapters.
University Medical Center Hamburg-Eppendorf (UKE), University Children's Hospital
Martinistr. 52
20246 Hamburg, Germany
2022 - 2020
|
Vice-Chairman of the Department of Pediatrics |
2019
|
Head of the Divison of pediatric Nephrology, pediatric Hepatology and pediatric Transplantation |
1989 - 1995
|
University of Heidelberg, Tokyo and UCSD |
2006 - 2020
|
Board Certification for Pediatrics |
2007
|
Board Certification for Pediatric Nephrology |
2008
|
Board Cetrification for Pediatric Gastroenterology and Hepatology |
2011
|
Habilitation (Assistant/Associate Professor) |
2020
|
Board Certification for Transplantation Medicine |
2021
|
Full Professor for Pediatrics and Pediatric Transplantation |
Clinical postgraduate education:
since 2011 | University of Hamburg, Department of Pediatrics |
2007 - 2010 | University of Duesseldorf, Department of Pediatrics |
2004 - 2007 | University of Heidelberg, Department of Pediatrics |
2002 - 2004 | Albert Einstein School of Medicine, Bronx, NY, USA |
1995 - 2002 | University of Heidelberg, Department of Pediatrics |
2016- 2020
|
Teacher of the year (Medical School UKE) |
2014
|
Research Award of the Jackstädt-Foundation |
2014
|
Research Award of the Peter Stiftung |
2012
|
Research Award of the Novartis-Foundation |
2011 | Research Award of the University of Duesseldorf |
2008 | Award of the German Society of Pediatric Nephrology |
1. | The calcium-sensing receptor stabilizes podocyte function in proteinuric humans and mice. |
2. | mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy. |
3. | An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis. |
4. | Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS) |
5. | Innovating and invigorating the clinical trial infrastructure for glomerular diseases. |
6. | A pediatric gateway initiative for glomerular disease: introducing PIONEER. |
7. | Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial. |
8. | Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children. |
9. | Podocytes Produce and Secrete Functional Complement C3 and Complement Factor H |
10. | Current understandings in treating children with steroid-resistant nephrotic syndrome. |
Martinistraße 52
Campus Research N27
20246 Hamburg Germany